Pmv Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +14.8% | -18.0% | -3.5% | +2.6% | +299.0% | -9.0% | -88.4% | |
| – | -15.8% | +112.9% | +176.3% | +90.9% | +21.4% | -28.3% | -33.2% | |
| – | -29.4% | +127.8% | +207.2% | +47.6% | – | – | – | |
| – | +201.6% | -144.0% | – | -113.8% | – | -129.3% | – | |
| – | -75.9% | +35.8% | +811.5% | +491.8% | -88.0% | -31.9% | -95.6% | |
| – | -85.1% | +763.9% | -614.4% | -99.0% | +3,594.8% | – | +31.5% | |
| – | – | – | -99.3% | -52.6% | – | – | – | |
| – | +0.0% | +374.0% | -99.3% | -52.6% | +3,613.7% | -99.1% | +61.3% | |
| – | +559.6% | +570.6% | -165.3% | – | – | – | -223.2% | |
| – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.